Chief Scientific Officer
Dr. Dan Rock is the chief scientific officer at Cartography Biosciences, where he guides the company’s scientific strategy and leads the effort to advance Cartography’s internal programs into the clinic. Before joining Cartography, Dan was the vice president of pharmacokinetics, dynamics, metabolism, and bioanalytics at Merck. He was also the global head of pharmacokinetics and drug metabolism at Amgen, where he rose through the R&D organization after joining as a Senior Scientist. In his 20+ years in the industry, Dan has played a pivotal role in the design and optimization of 16+ clinical stage molecules, including multiple bispecific T-cell engagers and ADCs. He remains active in drug discovery research with over 70 publications and has advanced numerous in vitro technologies to accelerate design cycle times for biologic therapies. He earned his Ph.D. in physical chemistry from Washington State University and his B.S. in chemistry from University of Northern Colorado.